Related Experiment Video
Updated: Dec 26, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Echocardiographic predictors of interatrial block in patients with severe chronic kidney disease
Macit Kalçık1, Mucahit Yetim2, Tolga Doğan2
1Department of Cardiology, Faculty of Medicine, Hitit University, Buharaevler Mah. Buhara 25. Sok. No:1/A Daire:22, Çorum, Turkey. macitkalcik@yahoo.com.
Insights
Interatrial block (IAB), a delay in atrial conduction, is linked to left atrial enlargement and left ventricular hypertrophy in severe chronic kidney disease (CKD) patients. Echocardiographic findings like increased left atrial diameter predict IAB, aiding risk stratification.
Area of Science:
- Cardiology
- Nephrology
- Medical Imaging
Background:
- Interatrial block (IAB) signifies delayed conduction between atria, indicated by prolonged P-wave duration on ECG.
- Cardiovascular diseases are a primary cause of mortality in chronic kidney disease (CKD).
- Previous research highlights IAB prevalence and its association with atrial fibrillation and ischemic stroke risk.
Purpose of the Study:
- To identify echocardiographic predictors of interatrial block (IAB) in patients with severe chronic kidney disease (CKD).
Main Methods:
- 155 patients with severe CKD (GFR < 30 mL/min) underwent ECG and transthoracic echocardiography.
- IAB was defined as a P wave duration ≥ 120 ms on ECG.
- Echocardiographic parameters were analyzed to identify predictors of IAB.
Main Results:
- IAB was detected in 54 patients.
- Patients with IAB showed significantly increased left atrial diameter (LAD), left ventricular mass index (LVMI), and prevalence of left ventricular hypertrophy.
- Increased LAD and LVMI were identified as independent predictors of IAB.
Conclusions:
- A strong association exists between IAB and echocardiographic markers of left ventricular hypertrophy and left atrial dilatation.
- IAB may serve as an accessible marker for risk stratification in severe CKD patients.
- Echocardiography can help identify patients with severe CKD at higher risk for IAB.
Background:
Interatrial block (IAB), defined as a conduction delay between the right and left atrium, is manifested on the electrocardiogram as a prolonged P-wave duration. Large number of studies recently have been published regarding the prevalence of IAB and its associations with the risk of atrial fibrillation and ischemic stroke. Cardiovascular diseases are the leading causes of mortality in chronic kidney disease (CKD). In this study, we aimed to investigate echocardiographic predictors of IAB in patients with severe CKD.
Methods:
This study enrolled a total of 155 patients [male: 95 (61.3%), mean age: 56.3 ± 12.8 years] with severe CKD (glomerular filtration rate < 30 mL/min). All patients were evaluated by electrocardiography and transthoracic echocardiography. IAB was defined as P wave duration of ≥ 120 ms on electrocardiography.
Results:
Electrocardiography revealed IAB in 54 patients. The baseline demographic characteristics of the patients were similar in both groups with and without IAB. Left atrial diameter (LAD), left ventricular end-systolic and end-diastolic diameters, interventricular septal thickness, posterior wall thickness, left ventricular mass, left ventricular mass index (LVMI), and the prevalence of left ventricular hypertrophy were found to be significantly increased in patients with IAB. Increased LAD (OR = 1.119; 95% CI 1.019-1.228; p = 0.019) and LVMI (OR = 1.036; 95% CI 1.003-1.070; p = 0.031) were found to be independent predictors of IAB.
Conclusion:
A significant association exists between the presence of IAB and echocardiographic parameters related to left ventricular hypertrophy and left atrial dilatation. Presence of IAB may be an additional and easy diagnostic marker for risk stratification of patients with severe CKD.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Kidney Disease IV: Nursing Management

